Related Experiment Videos
Direct detection of HIV RNA expression in seropositive subjects
C Hart1, G Schochetman, T Spira
1AIDS Program, Centers for Disease Control, Atlanta, Georgia.
Lancet (London, England)
|September 10, 1988
Summary
Sensitive polymerase chain reaction (PCR) detected human immunodeficiency virus type 1 (HIV-1) RNA in blood cells of infected individuals, including those without symptoms. This method shows promise for monitoring HIV treatment and viral load.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection can persist asymptomatically.
- Monitoring viral load and treatment efficacy is crucial for managing HIV-1.
- Traditional diagnostic methods may not always detect low levels of viral RNA.
Purpose of the Study:
- To evaluate the utility of polymerase chain reaction (PCR) and reverse transcription for detecting HIV-1 RNA expression.
- To compare PCR-based RNA detection with DNA PCR and serum antigen assays.
- To assess the suitability of PCR for monitoring antiviral therapy and viral load in HIV-1 infected individuals.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) were collected from HIV-1 seropositive subjects.
- RNA was extracted and analyzed using reverse transcription and PCR (RT-PCR) to detect HIV-1 RNA.
- DNA PCR was performed on the same samples to detect HIV proviral DNA.
- Serum HIV antigen levels were measured for comparison.
Main Results:
- HIV-1 RNA was detected in PBMCs from asymptomatic individuals and those with symptomatic HIV-1 infection.
- HIV proviral DNA was found in 94% of samples.
- HIV-1 RNA was detected in 65% of DNA-positive samples, including those from patients on antiviral treatment.
- Serum HIV antigen assays detected only 32% of PCR-positive samples.
Conclusions:
- RT-PCR is a highly sensitive method for detecting HIV-1 RNA in PBMCs.
- This technique can identify viral RNA even in patients undergoing antiviral therapy.
- PCR offers a rapid and sensitive approach for monitoring HIV-1 viral load and treatment response.